4.325

2.98% 0.135

Ironwood Pharmaceuticals Inc (IRWD)

Overview News Price History Option Chain Financials Discussions Forecast

Ironwood Pharmaceuticals Inc stock is traded at $4.325, with a volume of 524.07K. It is up +2.98% in the last 24 hours and up +0.35% over the past month. Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Previous Close:

$4.19

Open:

$4.12

24h Volume:

524.07K

Relative Volume:

0.29

Market Cap:

$674.77M

Revenue:

$400.57M

Net Income/Loss:

$9.21M

P/E Ratio:

-0.7161

EPS:

-6.04

Net Cash Flow:

$146.36M

1W Performance:

+1.53%

1M Performance:

+0.35%

6M Performance:

-46.86%

1Y Performance:

-54.58%

1-Day Range:

$4.06

$4.33

1-Week Range:

$3.93

$4.35

52-Week Range:

$3.79

$15.70

Ironwood Pharmaceuticals Inc Stock (IRWD) Company Profile

Name

Ironwood Pharmaceuticals Inc

Sector

Healthcare (1181)

Industry

Drug Manufacturers - Specialty & Generic (88)

Phone

617-621-7722

Address

100 SUMMER STREET, SUITE 2300, BOSTON, MA

Employee

267

Twitter

@ironwoodpharma

Next Earnings Date

2024-11-07

Latest SEC Filings

IRWD's Discussions on Twitter

Ironwood Pharmaceuticals Inc Stock (IRWD) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-17-24	Initiated	Craig Hallum	Buy
Dec-14-23	Initiated	Wells Fargo	Overweight
Nov-09-23	Initiated	Jefferies	Buy
Sep-28-23	Initiated	JMP Securities	Mkt Outperform
Sep-02-22	Initiated	CapitalOne	Overweight
Apr-22-22	Initiated	Piper Sandler	Overweight
Sep-30-20	Downgrade	Wells Fargo	Overweight → Equal Weight
Jun-17-20	Initiated	Northland Capital	Outperform
Jul-10-19	Resumed	Credit Suisse	Neutral
Mar-27-19	Upgrade	Morgan Stanley	Underweight → Equal-Weight
Feb-25-19	Upgrade	H.C. Wainwright	Sell → Neutral
Jan-24-19	Upgrade	JP Morgan	Underweight → Neutral
Nov-07-18	Downgrade	Credit Suisse	Outperform → Neutral
Nov-07-18	Downgrade	JP Morgan	Neutral → Underweight
Jul-23-18	Initiated	H.C. Wainwright	Sell
May-09-18	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Jan-05-18	Downgrade	BofA/Merrill	Buy → Underperform
Dec-06-17	Downgrade	Mizuho	Buy → Neutral
Jul-21-17	Downgrade	JP Morgan	Overweight → Neutral
May-03-17	Initiated	Wells Fargo	Outperform
Apr-07-17	Reiterated	Mizuho	Buy
Feb-22-17	Reiterated	Barclays	Equal Weight
Nov-04-16	Reiterated	Mizuho	Buy
Oct-24-16	Reiterated	Wedbush	Neutral
Oct-10-16	Reiterated	Mizuho	Buy
Sep-27-16	Reiterated	WallachBeth	Hold

View All

Ironwood Pharmaceuticals Inc Stock (IRWD) Latest News

02:25 AM

Vanguard Group Inc's Strategic Acquisition in Ironwood Pharmaceu - GuruFocus.com

02:25 AM

Nov 04, 2024

Ironwood Pharmaceuticals (NASDAQ:IRWD) Upgraded at StockNews.com - MarketBeat

Nov 04, 2024

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Shares Sold by Allspring Global Investments Holdings LLC - Defense World

Nov 04, 2024

Emerald Mutual Fund Advisers Trust Sells 446,757 Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - MarketBeat

Nov 04, 2024

Oct 31, 2024

Where Are They Now? Ironwood Pharmaceuticals - Life Science Leader Magazine

Oct 31, 2024

Ironwood Pharmaceuticals (IRWD) Scheduled to Post Earnings on Thursday - MarketBeat

Oct 31, 2024

Oct 29, 2024

What Do Analysts Think About Ironwood Pharmaceuticals Inc’s (NASDAQ:IRWD) Future? - Stocks Register

Oct 29, 2024

Oct 28, 2024

Short Bowel Syndrome Market to Show Remarkable Growth Trends - openPR

Oct 28, 2024

Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading 9.1% HigherHere's What Happened - MarketBeat

Oct 28, 2024

Ironwood Pharmaceuticals Shares Rise 10% on Positive Results in Bowel Disease Study - MarketWatch

Oct 28, 2024

Once-Weekly Apraglutide Showed Consistent Treatment Effect Across Baseline Demographics and Disease Characteristics in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF), According to New STARS Phase III Data from Ironwood at ACG 2 - Business Wire

Oct 28, 2024

Oct 27, 2024

Applied Therapeutics (NASDAQ:APLT) versus Ironwood Pharmaceuticals (NASDAQ:IRWD) Head-To-Head Analysis - Defense World

Oct 27, 2024

Oct 24, 2024

Ironwood Pharmaceuticals to Host Third Quarter 2024 Investor Update Call - Business Wire

Oct 24, 2024

Lacklustre Performance Is Driving Ironwood Pharmaceuticals, Inc.'s (NASDAQ:IRWD) Low P/S - Simply Wall St

Oct 24, 2024

Oct 21, 2024

Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Down 4.8%What's Next? - MarketBeat

Oct 21, 2024

Exchange Traded Concepts LLC Takes Position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Defense World

Oct 21, 2024

Oct 19, 2024

Financial Survey: Regulus Therapeutics (NASDAQ:RGLS) & Ironwood Pharmaceuticals (NASDAQ:IRWD) - Defense World

Oct 19, 2024

Oct 18, 2024

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Oct 18, 2024

Zacks Research Has Negative Outlook for IRWD FY2025 Earnings - Defense World

Oct 18, 2024

Oct 17, 2024

Zacks Research Research Analysts Decrease Earnings Estimates for Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - MarketBeat

Oct 17, 2024

Zacks Research Analysts Lower Earnings Estimates for Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Defense World

Oct 17, 2024

Wedge Capital Management L L P NC Purchases Shares of 314,843 Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - MarketBeat

Oct 17, 2024

The Manufacturers Life Insurance Company Trims Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Defense World

Oct 17, 2024

Oct 16, 2024

State Street Corp's Strategic Acquisition of Ironwood Pharmaceuticals Shares - Yahoo Finance

Oct 16, 2024

Is Ironwood Pharmaceuticals, Inc. (IRWD) the Penny Stock with the Biggest Upside Potential According to Analysts? - Insider Monkey

Oct 16, 2024

Q1 2025 EPS Estimates for Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Cut by Analyst - MarketBeat

Oct 16, 2024

Oct 15, 2024

Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Up 5.1%What's Next? - MarketBeat

Oct 15, 2024

Leerink Partners gives a Market perform recommendation for Ironwood Pharmaceuticals Inc (IRWD) - Knox Daily

Oct 15, 2024

Oct 14, 2024

Financial Metrics Exploration: Understanding Ironwood Pharmaceuticals Inc (IRWD) Through Ratios - The Dwinnex

Oct 14, 2024